Lisa Tuomi

Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results.

A. Antoszyk, C. Chung, Carol Y Chung, 2008, American journal of ophthalmology.